Scutellarin Improves Type 2 Diabetic Cardiomyopathy by Regulating Cardiomyocyte Autophagy and Apoptosis

Figure 1

SCU reduces blood glucose and lipid factors and improves cardiac function in the T2DC model. (a) SCU reduced the concentration of fasting glucose in the serum. (b) SCU reduced heart weight/body weight. (c) SCU reduced the concentration of LDH1 and CK. (d) SCU suppressed lipid accumulation. The values shown are the (SEM) of the data from three independent experiments. ^#Significant compared with the control group alone, . Significant compared with the model group alone, .

(a)

(b)

(c)

(d)